Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy.
Konstantinos KaratoliosGeorgios ChatzisVolker HolzendorfStefan StörkAnette RichterDavis BinasBernhard SchiefferSabine PankuweitPublished in: Disease markers (2018)
Our study suggests that baseline galectin-3 is an independent predictor of LVRR. Low levels of galectin-3 may be regarded a useful biomarker of favorable ventricular remodeling in patients with RODCM.